Published in Br J Pharmacol on August 01, 1998
Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev (2014) 0.96
Pharmacological characterization of the cardiovascular responses elicited by kinin B(1) and B(2) receptor agonists in the spinal cord of streptozotocin-diabetic rats. Br J Pharmacol (2000) 0.89
Functional magnetic resonance imaging of the spinal cord during sensory stimulation in diabetic rats. J Magn Reson Imaging (2009) 0.77
The effect of long-term streptozotocin-induced diabetes on contractile and relaxation responses of coronary arteries: selective attenuation of CGRP-induced relaxations. Br J Pharmacol (2000) 0.75
Calcitonin gene-related peptide is a potent vasodilator. Nature (1985) 6.13
Does rectal gonorrhoea reflect unsafe sex? Lancet (1991) 3.99
Neutrophils in development of multiple organ failure in sepsis. Lancet (2006) 3.64
Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br J Pharmacol (1985) 2.38
A flow-sensitive apparatus for studying the responses of the constrictor muscles of perfused tubular organs [proceedings]. J Physiol (1978) 2.14
Preventing the spread of HIV infection. BMJ (1991) 1.88
Potent vasodilator activity of calcitonin gene-related peptide in human skin. J Invest Dermatol (1986) 1.68
The identification of hydroxy fatty acids in psoriatic skin. Prostaglandins (1983) 1.59
A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy. FASEB J (2001) 1.59
Psoriasis and leukotriene B4. Lancet (1982) 1.54
Diabetic neuropathy, nerve growth factor and other neurotrophic factors. Trends Neurosci (1994) 1.50
Evidence that endogenous nitric oxide modulates oedema formation induced by substance P. Eur J Pharmacol (1990) 1.45
Essential fatty acid treatment prevents nerve ischaemia and associated conduction anomalies in rats with experimental diabetes mellitus. Diabetologia (1993) 1.44
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group. Int J STD AIDS (1996) 1.38
Evidence for the role of neurogenic inflammation components in trypsin-elicited scratching behaviour in mice. Br J Pharmacol (2008) 1.29
Effect of a calcitonin gene-related peptide antagonist (CGRP8-37) on skin vasodilatation and oedema induced by stimulation of the rat saphenous nerve. Br J Pharmacol (1993) 1.29
The involvement of noradrenergic nerves in the cardiovascular reflex responses to lower body negative pressure in the anaesthetised rabbit. Pflugers Arch (1976) 1.29
Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats. Diabetologia (1983) 1.21
A pharmacologic analysis of mechanical hyperalgesia in streptozotocin/diabetic rats. Pain (1998) 1.20
Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. Diabetes (1999) 1.16
A calcitonin gene-related peptide (CGRP) antagonist (CGRP8-37) inhibits microvascular responses induced by CGRP and capsaicin in skin. Br J Pharmacol (1991) 1.16
Inflammatory edema induced by interactions between IL-1 and the neuropeptide calcitonin gene-related peptide. J Immunol (1991) 1.14
Time-dependent synergistic interactions between the vasodilator neuropeptide, calcitonin gene-related peptide (CGRP) and mediators of inflammation. Br J Pharmacol (1991) 1.11
Insulin and insulin-like growth factor I enhance regeneration in cultured adult rat sensory neurones. Brain Res (1993) 1.10
An analysis of the spectra of genetic activity produced by known or suspected human carcinogens. Mutat Res (1985) 1.10
Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors. Diabetes (1997) 1.09
Genetic activity profiles and pattern recognition in test battery selection. Mutat Res (1988) 1.08
Interaction of adenine nucleotides with multiple binding sites on beef heart mitochondrial adenosine triphosphatase. J Biol Chem (1975) 1.08
Aldose reductase inhibitors and their potential for the treatment of diabetic complications. Trends Pharmacol Sci (1994) 1.08
Nitric oxide-dependent release of vasodilator quantities of calcitonin gene-related peptide from capsaicin-sensitive nerves in rabbit skin. Br J Pharmacol (1994) 1.08
A role for substance P in arthritis? Neurosci Lett (2004) 1.05
Evaluation of the genetic activity profiles of 65 pesticides. Mutat Res (1986) 1.05
Leukotriene B4-like material in scale of psoriatic skin lesions. Br J Pharmacol (1984) 1.05
Further evidence for the involvement of microtubules in the intra-axonal movement of noradrenaline storage granules. J Physiol (1971) 1.03
Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil. Diabetes (1984) 1.03
Effect of three animal models of inflammation on nerve fibres in the synovium. Ann Rheum Dis (1994) 1.03
Action of calcitonin gene-related peptide upon bovine vascular endothelial and smooth muscle cells grown in isolation and co-culture. Br J Pharmacol (1990) 1.03
Trigeminal ganglion stimulation increases facial skin blood flow in the rat: a major role for calcitonin gene-related peptide. Brain Res (1995) 1.02
Nerve growth factor induced hyperalgesia in the rat hind paw is dependent on circulating neutrophils. Pain (1998) 1.00
Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition. Diabetologia (1983) 1.00
Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation. Neuroscience (2005) 0.99
Human recombinant nerve growth factor replaces deficient neurotrophic support in the diabetic rat. Eur J Neurosci (1995) 0.98
Use of NK(1) knockout mice to analyze substance P-induced edema formation. Am J Physiol (1999) 0.98
Rapid breakdown of diphosphoinositide and triphosphoinositide in erythrocyte membranes. J Cell Physiol (1976) 0.98
Activation of group II metabotropic glutamate receptors underlies microglial reactivity and neurotoxicity following stimulation with chromogranin A, a peptide up-regulated in Alzheimer's disease. J Neurochem (2002) 0.98
The Genetic Activity Profile database. Environ Health Perspect (1991) 0.97
Hypoxic neuropathy: relevance to human diabetic neuropathy. Diabetologia (1990) 0.96
Responses to endothelins in the rat cutaneous microvasculature: a modulatory role of locally-produced nitric oxide. Br J Pharmacol (1992) 0.95
The role of bradykinin B1 receptors in the maintenance of intra-articular plasma extravasation in chronic antigen-induced arthritis. Br J Pharmacol (1994) 0.94
A second form of human calcitonin gene-related peptide which is a potent vasodilator. Eur J Pharmacol (1986) 0.94
Nerve ischaemia in diabetic rats: time-course of development, effect of insulin treatment plus comparison of streptozotocin and BB models. Diabetologia (1994) 0.94
A vitamin D(3) derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats. Diabetologia (1999) 0.94
Neurogenic influences on contralateral responses during experimental rat monoarthritis. Brain Res (1995) 0.94
Phoneutria nigriventer (armed spider) venom induces increased vascular permeability in rat and rabbit skin in vivo. Toxicon (1992) 0.93
Nerve growth factor modulates the activation status and fast axonal transport of ERK 1/2 in adult nociceptive neurones. Mol Cell Neurosci (2001) 0.93
Differential role of corticotrophin-releasing factor receptor types 1 and 2 in stress-induced suppression of pulsatile luteinising hormone secretion in the female rat. J Neuroendocrinol (2006) 0.93
Oxidative stress participates in the breakdown of neuronal phenotype in experimental diabetic neuropathy. Diabetologia (2001) 0.93
Ruthenium red selectively inhibits oedema formation and increased blood flow induced by capsaicin in rabbit skin. Br J Pharmacol (1990) 0.92
Mechanism of bradykinin-induced plasma extravasation in the rat knee joint. Br J Pharmacol (1995) 0.92
Neutrophil sorbitol production impairs oxidative killing in diabetes. Diabet Med (1987) 0.91
Response and cosmetic outcome of two fractionation regimens for AIDS-related Kaposi's sarcoma. Radiother Oncol (1998) 0.91
Essential role for nitric oxide in neurogenic inflammation in rat cutaneous microcirculation. Evidence for an endothelium-independent mechanism. Circ Res (1995) 0.91
Nerve growth factor- and neurotrophin-3-induced changes in nociceptive threshold and the release of substance P from the rat isolated spinal cord. J Neurosci (1997) 0.90
Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; comparison with essential fatty acids. Diabetologia (1995) 0.90
NMDA receptor activation modulates evoked release of substance P from rat spinal cord. Br J Pharmacol (1998) 0.90
Structure-activity relationship of human calcitonin-gene-related peptide. Biochem J (1990) 0.90
Effects of treatment with myo-inositol or its 1,2,6-trisphosphate (PP56) on nerve conduction in streptozotocin-diabetes. Eur J Pharmacol (1993) 0.89
Enhanced vascular responses to adrenomedullin in mice overexpressing receptor-activity-modifying protein 2. Circ Res (2005) 0.89
Effect of the inducible nitric oxide synthase inhibitors aminoguanidine and L-N6-(1-iminoethyl)lysine on zymosan-induced plasma extravasation in rat skin. J Immunol (1997) 0.89
Neonatal lipopolysaccharide exposure exacerbates stress-induced suppression of luteinizing hormone pulse frequency in adulthood. Endocrinology (2007) 0.89
STI prevention and the male sex industry in London: evaluating a pilot peer education programme. Sex Transm Infect (2000) 0.88
Nerve growth factor treatment increases stimulus-evoked release of sensory neuropeptides in the rat spinal cord. Eur J Neurosci (1997) 0.88
Coexistence of nerve conduction deficit with increased Na(+)-K(+)-ATPase activity in galactose-fed mice. Implications for polyol pathway and diabetic neuropathy. Diabetes (1990) 0.88
Expression of neuropeptides in experimental diabetes; effects of treatment with nerve growth factor or brain-derived neurotrophic factor. Brain Res Mol Brain Res (1994) 0.88
Leukotrienes C4 and D4 in psoriatic skin lesions. Prostaglandins (1985) 0.88
Vasodilator responses to calcitonin gene-related peptide (CGRP) and amylin in the rat isolated perfused kidney are mediated via CGRP1 receptors. J Pharmacol Exp Ther (1994) 0.88
Target tissue production and axonal transport of neurotrophin-3 are reduced in streptozotocin-diabetic rats. Diabetologia (1998) 0.87
Neurotrophin-3 reverses nerve conduction velocity deficits in streptozotocin-diabetic rats. J Peripher Nerv Syst (1999) 0.87
Slow orthograde axonal transport of radiolabelled protein in sciatic motoneurones of rats with short-term experimental diabetes: effects of treatment with an aldose reductase inhibitor or myo-inositol. J Neurochem (1984) 0.87
Changes in preprotachykinin mRNA expression and substance P levels in dorsal root ganglia of monoarthritic rats: comparison with changes in synovial substance P levels. Brain Res (1995) 0.87
Independent learning packages (audio tape/pamphlet) for a course in cell excitation: evidence that they can be at least as effective as conventional lectures. Med Educ (1979) 0.87
Two populations or granular vesicles in constricted post-ganglionic sympathetic nerves. J Physiol (1975) 0.87
Olvanil: more potent than capsaicin at stimulating the efferent function of sensory nerves. Eur J Pharmacol (1992) 0.87
Potent vasoactive properties of endothelin 1 in human skin. J Appl Physiol (1985) (1991) 0.87
Altered neurotrophin mRNA levels in peripheral nerve and skeletal muscle of experimentally diabetic rats. J Neurochem (1995) 0.86
Inhibition by SR 140333 of NK1 tachykinin receptor-evoked, nitric oxide-dependent vasodilatation in the hamster cheek pouch microvasculature in vivo. Br J Pharmacol (1994) 0.86
Interaction of human adrenomedullin 13-52 with calcitonin gene-related peptide receptors in the microvasculature of the rat and hamster. Br J Pharmacol (1995) 0.86
Interaction between fluconazole and rifampicin. BMJ (1990) 0.85
Neurotrophins and peripheral neuropathy. Philos Trans R Soc Lond B Biol Sci (1996) 0.85
Slow component-a of axonal transport, nerve myo-inositol, and aldose reductase inhibition in streptozocin-diabetic rats. Diabetes (1986) 0.85
Proceedings: The noradrenaline concentration and the cholinesterase activity of the separated longitudinal and circular layers of muscle of the guinea-pig vas deferens. Br J Pharmacol (1974) 0.85
Impaired nerve regeneration in streptozotocin-diabetic rats. Effects of treatment with an aldose reductase inhibitor. J Neurol Sci (1989) 0.85
Prevention of defective axonal transport in streptozocin-diabetic rats by treatment with "Statil" (ICI 128436), an aldose reductase inhibitor. Diabetes (1985) 0.85